Microneedling has acquired an entire accessory industry. PRP. Exosomes. Growth factors. Vitamin cocktails. “Stem-cell” serums. A fairly basic procedure becomes a premium package with remarkable speed, and it happens before anyone has separated the evidence for the needles from the evidence for whatever is being placed on — or into — freshly treated skin.
I have sat on the paying side of enough of these menus to recognize the move. The needles get explained in detail. The vial that follows them gets explained with an adjective. Studying medical aesthetics did nothing except sharpen the reflex to ask which of the two I am actually being charged for.
- Systematic reviewWhat a verdict wants: people, randomized, followed long enough for the effect to be real rather than new.
- Randomized trialWhat a verdict wants: people, randomized, followed long enough for the effect to be real rather than new.
- Small human trialWhat a verdict wants: people, randomized, followed long enough for the effect to be real rather than new.
- Case seriesWhat the box usually cites. Real research, but a long way from your face — a reason to look, never proof.
- Animal modelWhat the box usually cites. Real research, but a long way from your face — a reason to look, never proof.
- In vitroWhat the box usually cites. Real research, but a long way from your face — a reason to look, never proof.
The FDA has authorized specific microneedling devices for specific aesthetic indications. It also states that microneedling devices are not approved for delivering cosmetics, topical medications, vitamin solutions, drugs, or blood products such as PRP into the skin. The device’s clearance and the add-on’s evidence are two different files. The package price staples them together.
| What is on the tray | Where it stands with the FDA | The one sentence you should be able to get |
|---|---|---|
| The microneedling device | Authorized for specific aesthetic indications. | Which of those indications is mine. |
| PRP | The agency has not cleared microneedling devices for use with PRP or other products. | Which preparation protocol you use, since the studies vary on preparation, platelet concentration, activation, delivery method and endpoints. |
| Exosomes | There are currently no FDA-approved exosome products, and the agency has warned about serious adverse events associated with unapproved ones. | What the exact product is, who makes it, and whether it is sold as a cosmetic, a drug or a biologic. |
| Growth-factor, vitamin and “stem-cell” serums | Covered by the same statement: devices are not approved for delivering cosmetics, topical medications, vitamin solutions or drugs into skin. | What is in it, whether it is sterile, and what it is doing that microneedling alone would not. |
Microneedling evidence does not transfer to the add-on by proximity
A study supporting microneedling for acne scars or wrinkles proves nothing about whether an exosome serum improves the result. Those are two separate literatures, and only one of them tends to get cited in the room.
“We use it after microneedling” is a workflow description. It is not evidence, however confidently it is delivered.
PRP and exosomes have different problems, and both get sold the same way
Platelet-rich plasma is prepared from your own blood and used across several medical and aesthetic contexts. Studies have examined PRP with microneedling for acne scars and other concerns — but protocols vary substantially in preparation, platelet concentration, activation, delivery method and endpoints, which makes the literature hard to shop from. The FDA’s device position is narrower and worth knowing precisely: the agency has not cleared microneedling devices for use with PRP or other products. That does not mean every clinician combining them is acting improperly. It means the combination cannot borrow the device’s clearance as proof of the combined treatment’s safety or effectiveness.
Exosomes deserve a harder question still. The FDA has stated there are currently no FDA-approved exosome products, and has previously warned about serious adverse events associated with unapproved products marketed as containing them. “Exosome facial” is a very polished phrase wrapped around a biologically complicated and essentially unregulated category. Ask what the exact product is, who manufactures it, how it is regulated, whether it is sold as a cosmetic, drug, or biologic, what sterility controls apply, and what human clinical evidence supports this specific use.
A murmured sentence about “cell-to-cell communication” is not an answer. It is a vocabulary word.
Freshly needled skin is not simply better at absorbing the good stuff
Microneedling deliberately disrupts the skin barrier — that controlled injury is the mechanism. It also transforms the exposure question. Ingredients that are perfectly well tolerated on intact skin are not automatically appropriate on tissue whose barrier has just been opened on purpose.
Fragrance, preservatives, acids, retinoids, nonsterile formulations, unvalidated compounded mixtures: the barrier you have just paid to open is exactly why none of those is a neutral choice any more. Which is why good post-procedure instructions are boring and specific, and why boring and specific is precisely what you want them to be.
“Medical grade” is reassurance, not a regulatory category
A clinic may describe an add-on as medical grade, regenerative, pharmaceutical grade, or professional-only. Each phrase sounds like an answer while avoiding all the useful questions: What is it? What is its regulatory status? What evidence supports this route of use? How is contamination prevented? What happens if there is a reaction?
Words that soothe are not words that inform. In this category the difference is worth actual money and occasionally actual skin.
Questions to ask before paying for the upgrade
- What exact product are you adding?
- Is it FDA-approved or cleared for this use — and if not, what is its regulatory status?
- What human evidence supports combining it with microneedling?
- How is it manufactured, stored, and kept sterile?
- Is it placed on the surface, or intentionally delivered into tissue?
- What additional risk does the add-on create beyond microneedling alone?
- What would microneedling alone be expected to accomplish?
- How much of the package price is the add-on?
That last question is clarifying in a way clinics don’t always enjoy. If the vial is half the price of the package, the vial should be able to defend itself.
The vial does not inherit the needle’s evidence
Microneedling can have a reasonable evidence base for selected indications. The expensive vial applied afterward does not inherit that evidence by sitting on the same tray.
PRP deserves its own evidence discussion. Exosomes deserve a stricter regulatory one. Serums deserve ingredient and sterility scrutiny. And if the clinic cannot tell you what the device contributes versus what the add-on contributes, then the package is doing more work than the proof — which is usually the moment to book the simpler version and keep the difference.
What the needles alone are cleared to do, and what gets sold beside them, is set out in the microneedling guide. And if the actual goal is scar remodeling rather than product delivery, the shape of the scar decides the tool — that sorting is in the acne-scar treatment map, and it is a cheaper place to start than another vial.
Checked against FDA device guidance, FDA consumer updates, and the FDA public safety notification on exosome products. Reviewed August 8, 2026.
This article is general education and does not determine whether a particular combination treatment is appropriate for an individual.
Source file
What this article is standing on
- FDA: Microneedling DevicesWhich microneedling devices are regulated as medical devices, and what claims put them there. The needle is regulated; whatever gets applied through the channels it makes is not — which is why the add-on has to be treated as a separate evidence question.
- FDA: Public Safety Notification on Exosome ProductsNo exosome product is FDA-approved, and therapeutic exosomes require premarket approval. A cleared microneedling device confers no status whatsoever on an exosome serum used with it.
- FDA Safety Communication: Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling (15 October 2025)Reported burns, scarring, fat loss, disfigurement and nerve damage at the energy-assisted end of this category. Applies to RF microneedling specifically, not to mechanical microneedling.
- FDA 510(k) Premarket Notification databaseWhere to check the cleared indications for the exact device model in the room.